Literature DB >> 311782

Serum amyloid A: evidence for its origin in polymorphonuclear leukocytes.

C J Rosenthal, L Sullivan.   

Abstract

In this study the presence of an amyloid A, antigenically related material was determined in four subpopulations of human leukocytes. Monocytes, granulocytes, thymus-derived lymphocytes, and bone marrow-derived and null lymphocytes were isolated from the peripheral blood of five apparently normal subjects, two patients with secondary amyloidosis, three patients with acute infections, and seven patients with metastatic cancer. Mononuclear leukocytes, isolated from the interface of a Ficoll-Hypaque gradient, were separated into monocytes, thymus-derived lymphocytes, and bone marrow-derived plus null lymphocytes by glass adherence and depletion of sheep erythrocyte rosette-forming lymphocytes. Granulocytes were isolated by sedimentation in 2% methyl cellulose from the erythrocyte-rich pellet formed at the bottom of the Ficoll-Hypaque gradient. The four isolated leukocyte subpopulations were cultured and, at varying intervals, the amyloid A content of the culture medium and of sonicated, 2 x 10(6) cells was determined by radioimmunoassay. Our results indicated a 2-14 times greater amount of amyloid A-related material in the sonicated granulocytes compared with the individuals' serum amyloid A levels. The mononuclear subpopulations showed a low or negligible amyloid A content. The amount of amyloid A antigenic material was further found to increase in cultured granulocytes, reaching a peak value between the 16th and 30th h of culture. The granulocytes of only two out of eight individuals tested released amyloid A antigenically related material into the culture medium. This release was found to be blocked by the presence of colchicine, vincristine, puromycin, or cycloheximide in the culture medium. In contrast, only the presence of puromycin or cycloheximide was shown to significantly inhibit the intracellular increase of amyloid A in the cultured granulocytes. Thus, it appears that among the circulating blood cells, the granulocytes produce amyloid A antigenically related material and could release it under conditions that remain to be further defined.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 311782      PMCID: PMC371882          DOI: 10.1172/JCI109237

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Synthesis and secretion of a mitogenic protein by macrophages: description of a superinduction phenomenon.

Authors:  E R Unanue; J M Kíely
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Amyloid AA protein. Cellular distribution and appearance.

Authors:  S Watanabe; E Jaffe; S Pollock; J Sipe; G Glenner
Journal:  Am J Clin Pathol       Date:  1977-06       Impact factor: 2.493

4.  Colchicine for familial Mediterranean fever.

Authors:  S E Goldfinger
Journal:  N Engl J Med       Date:  1972-12-21       Impact factor: 91.245

5.  Immunochemical studies on the nature of the serum component (SAA) related to secondary amyloidosis.

Authors:  T F Ignaczak; J D Sipe; F P Linke; G G Glenner
Journal:  J Lab Clin Med       Date:  1977-05

6.  Prolonged colchicine treatment in four patients with amyloidosis.

Authors:  M Ravid; M Robson; I Kedar
Journal:  Ann Intern Med       Date:  1977-11       Impact factor: 25.391

7.  Casein-induced experimental amyloidosis. VI. A pathogenic role for b cells in the murine model.

Authors:  M A Scheinberg; E S Cathcart
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

8.  Kinetics of serum amyloid protein A in casein-induced murine amyloidosis.

Authors:  M D Benson; M A Scheinberg; T Shirahama; E S Cathcart; M Skinner
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

9.  Variation with age and disease of an amyloid A protein-related serum component.

Authors:  C J Rosenthal; E C Franklin
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

10.  Localization of amyloid-related serum protein SAA-like material to intermediate (10 nm) filaments of cultured human embryonal fibroblasts.

Authors:  E Linder; V P Lehto; I Virtanen; S Stenman; J B Natvig
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

View more
  16 in total

1.  Amyloidosis.

Authors:  W V Epstein; N Rizk
Journal:  West J Med       Date:  1979-04

2.  Isolation and characterization of the amyloid-related apoprotein (SAA) from human high density lipoprotein.

Authors:  N Eriksen; E P Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

Review 3.  Reactive (secondary) amyloidosis and its pathogenesis.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

4.  Metabolism of the serum amyloid A proteins (SSA) in high-density lipoproteins and chylomicrons of nonhuman primates (vervet monkey).

Authors:  J S Parks; L L Rudel
Journal:  Am J Pathol       Date:  1983-09       Impact factor: 4.307

5.  The degradation of serum amyloid A protein by activated polymorphonuclear leucocytes: participation of granulocytic elastase.

Authors:  S L Silverman; E S Cathcart; M Skinner; A S Cohen
Journal:  Immunology       Date:  1982-08       Impact factor: 7.397

6.  Induction of hepatic synthesis of serum amyloid A protein and actin.

Authors:  J F Morrow; R S Stearman; C G Peltzman; D A Potter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

7.  Serum amyloid A (SAA) in viral infection: rubella, measles and subacute sclerosing panencephalitis (SSPE).

Authors:  R Shainkin-Kestenbaum; S Zimlichman; Y Winikoff; M Pras; C Chaimovitz; I Sarov
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

8.  Ultrastructural studies on the evolution of amyloidosis in the cyclic hematopoietic (CH) dog.

Authors:  E A Machado; J B Jones; R D Lange
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-07-31

9.  Amyloidosis and the serum amyloid A protein response to muramyl dipeptide analogs and different mycobacterial species.

Authors:  K P McAdam; N T Foss; C Garcia; R DeLellis; L Chedid; R J Rees; S M Wolff
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

10.  Serum amyloid A protein, apolipoprotein A-I, and apolipoprotein B during the course of acute myocardial infarction.

Authors:  C P Maury; K J Tötterman; C G Gref; C Ehnholm
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.